Diagyn and MEDPNC, along with other leading and innovative Israeli companies, took part in the 1st World Congress on Women’s Health Innovations and Inventions that was held at The Tel Aviv Hilton Hotel July 10-11, 2019, addressing specific unmet needs in women’s health.
The event was covered by journalists from Israel and from around the world.
At the congress Diagyn’s CEO, Dr. Diana Ickowicz, presented the company’s solution for unmet needs in the field of precision chemotherapy for ovarian cancer patients that will contribute to patients’ survival rates and quality of life.
Dr. Nataly Kravchenko-Balasha, MEDPNC’s Chief Scientist, presented the company’s developments for the prediction of efficient personalized drug combinations for the treatment of individual cancer patients, according to their altered protein network structure.She was interviewed by the National Bulgarian radio station and answered questions about the innovative process and technology of the company.
The congress’s objective was to bring together technology experts, physicians, healthcare providers and research and development companies, involved in shaping future solutions in the field of women’s health.